tetano
Editor, Senior Moderator
Pathogens
. 2022 Nov 21;11(11):1389.
doi: 10.3390/pathogens11111389.
Clinical Evaluation of Three Commercial RT-PCR Kits for Routine COVID-19 Diagnosis
Rifat Tasnim Juthi[SUP] 1 [/SUP], Saiful Arefeen Sazed[SUP] 1 [/SUP], Md Fahad Zamil[SUP] 1 [/SUP], Mohammad Shafiul Alam[SUP] 1 [/SUP]
Affiliations
Abstract
Amongst the multiple ways to diagnose coronavirus disease-2019 (COVID-19), reverse transcription polymerase chain reaction (RT-PCR) remains the reference gold standard, providing fast and accurate results. This study evaluated and compared the performance of three commercially available COVID-19 RT-PCR kits-Aridia[SUP]®[/SUP] COVID-19 Real-Time PCR Test (CTK Biotech, Inc., Poway, CA, USA), Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (Sansure Biotech Inc., Changsha, China) and Allplex[SUP]TM[/SUP] 2019-nCoV assay (Seegene Inc., Seoul, Republic of Korea) for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A total of 326 clinically suspected patients were enrolled for the study, and among them, 209 were diagnosed as positive and 117 as negative when tested with the reference method, US CDC 2019-Novel Coronavirus (2019-nCoV) Real Time RT-PCR Diagnostic Panel. The Aridia[SUP]®[/SUP] kit showed total agreement with the reference test, with a sensitivity of 100% (95% CI: 98.25% to 100.0%) and a specificity of 100% (96.90% to 100.00%). The Allplex[SUP]TM[/SUP] kit also showed 100% specificity (95% CI: 96.90% to 100.00%), but a lower sensitivity (98.09%, 95% CI: 95.17% to 99.48%). Among the three kits, the Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit showed the worst performance, with a sensitivity of 98.6% (95% CI: 95.9% to 99.7%) and a specificity of 95.73, 95% (CI: 90.31% to 98.60%). While all these kits conform to the requirement for routine molecular diagnosis with high performances, the Aridia[SUP]®[/SUP] COVID-19 Real-Time PCR Test showed the best performance among the three kits.
Keywords: COVID-19; RT-PCR; RT-PCR kit; SARS-CoV-2; diagnostics; real time PCR; real time RT-PCR.
. 2022 Nov 21;11(11):1389.
doi: 10.3390/pathogens11111389.
Clinical Evaluation of Three Commercial RT-PCR Kits for Routine COVID-19 Diagnosis
Rifat Tasnim Juthi[SUP] 1 [/SUP], Saiful Arefeen Sazed[SUP] 1 [/SUP], Md Fahad Zamil[SUP] 1 [/SUP], Mohammad Shafiul Alam[SUP] 1 [/SUP]
Affiliations
- PMID: 36422640
- DOI: 10.3390/pathogens11111389
Abstract
Amongst the multiple ways to diagnose coronavirus disease-2019 (COVID-19), reverse transcription polymerase chain reaction (RT-PCR) remains the reference gold standard, providing fast and accurate results. This study evaluated and compared the performance of three commercially available COVID-19 RT-PCR kits-Aridia[SUP]®[/SUP] COVID-19 Real-Time PCR Test (CTK Biotech, Inc., Poway, CA, USA), Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (Sansure Biotech Inc., Changsha, China) and Allplex[SUP]TM[/SUP] 2019-nCoV assay (Seegene Inc., Seoul, Republic of Korea) for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A total of 326 clinically suspected patients were enrolled for the study, and among them, 209 were diagnosed as positive and 117 as negative when tested with the reference method, US CDC 2019-Novel Coronavirus (2019-nCoV) Real Time RT-PCR Diagnostic Panel. The Aridia[SUP]®[/SUP] kit showed total agreement with the reference test, with a sensitivity of 100% (95% CI: 98.25% to 100.0%) and a specificity of 100% (96.90% to 100.00%). The Allplex[SUP]TM[/SUP] kit also showed 100% specificity (95% CI: 96.90% to 100.00%), but a lower sensitivity (98.09%, 95% CI: 95.17% to 99.48%). Among the three kits, the Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit showed the worst performance, with a sensitivity of 98.6% (95% CI: 95.9% to 99.7%) and a specificity of 95.73, 95% (CI: 90.31% to 98.60%). While all these kits conform to the requirement for routine molecular diagnosis with high performances, the Aridia[SUP]®[/SUP] COVID-19 Real-Time PCR Test showed the best performance among the three kits.
Keywords: COVID-19; RT-PCR; RT-PCR kit; SARS-CoV-2; diagnostics; real time PCR; real time RT-PCR.